AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ACVR1B | Activin A receptor, type IB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADCY1 | Adenylate cyclase 1 (brain) | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
AJUBA | Ajuba LIM protein | Cancer-related genes
| | | | | Tissue enhanced |
AK9 | Adenylate kinase 9 | Cancer-related genes Enzymes
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
ANAPC1 | Anaphase promoting complex subunit 1 | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
ANKRD12 | Ankyrin repeat domain 12 | Cancer-related genes
| | | | | Expressed in all |
APAF1 | Apoptotic peptidase activating factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARHGAP32 | Rho GTPase activating protein 32 | Cancer-related genes
| | | | | Expressed in all |
ARHGAP35 | Rho GTPase activating protein 35 | Cancer-related genes
| | | | | Expressed in all |
ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARID5B | AT rich interactive domain 5B (MRF1-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ASPM | Asp (abnormal spindle) homolog, microcephaly associated (Drosophila) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
ATG13 | Autophagy related 13 | Cancer-related genes
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATR | Ataxia telangiectasia and Rad3 related | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| | | | | Mixed |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CBFB | Core-binding factor, beta subunit | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CCAR1 | Cell division cycle and apoptosis regulator 1 | Cancer-related genes
| | | | | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Cancer-related genes
| | | | | Expressed in all |
CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Cancer-related genes Disease related genes
| | | | | Expressed in all |